Finepoint Capital

Latest statistics and disclosures from Finepoint Capital's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are SPY, QXO, IWM, RXO, SLDB, and represent 99.99% of Finepoint Capital's stock portfolio.
  • Added to shares of these 2 stocks: SPY (+$249M), RXO (+$27M).
  • Reduced shares in these 1 stock: QXO (-$22M).
  • Finepoint Capital was a net buyer of stock by $255M.
  • Finepoint Capital has $2.0B in assets under management (AUM), dropping by 15.25%.
  • Central Index Key (CIK): 0001608126

Tip: Access up to 7 years of quarterly data

Positions held by Finepoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Finepoint Capital

Finepoint Capital holds 9 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) 53.5 $1.1B +30% 1.6M 681.92
 View chart
Qxo Com New (QXO) 20.4 $409M -5% 21M 19.29
 View chart
Ishares Tr Russell 2000 Etf Put Option (IWM) 19.9 $398M 1.6M 246.16
 View chart
Rxo Common Stock (RXO) 5.9 $119M +29% 9.4M 12.64
 View chart
Solid Biosciences Com New (SLDB) 0.3 $5.4M 961k 5.64
 View chart
Aleanna Com Cl A (ANNA) 0.0 $79k 28k 2.85
 View chart
Aleanna *w Exp 12/13/202 (ANNAW) 0.0 $69k 490k 0.14
 View chart
MoneyHero *w Exp 09/13/202 (MNYWW) 0.0 $38k 895k 0.04
 View chart
Calidi Biotherapeutics Com New (CLDI) 0.0 $1.2k 1.0k 1.17
 View chart

Past Filings by Finepoint Capital

SEC 13F filings are viewable for Finepoint Capital going back to 2014

View all past filings